Simplified Diagnostic Algorithm for Evaluation of Neonates With Prenatally Detected Hydronephrosis
NCT ID: NCT01330511
Last Updated: 2011-04-07
Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
COMPLETED
Total Enrollment
76 participants
Study Classification
OBSERVATIONAL
Study Start Date
2005-01-31
Study Completion Date
2010-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients with congenital hydronephrosis will be identified by inpatient consultations performed by Dr. Assadi for congenital hydronephrosis and by outpatient problem lists with congenital hydronephrosis of Dr. Assadi's existing patients. Given standard evaluation will be evaluated to determine if based on initial ultrasound classification an algorithm can be developed to target evaluation studies for the initial evaluation. With a goal of targeting the few children that have need of additional intervention and minimizing the studies performed on children who will spontaneously resolve.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Alkaline Citrate Treatment to Lower the Risk of Nephrocalcinosis in Preterm Infants
NCT00249951
Nephrocalcinosis
COMPLETED
PHASE3
Do Elevated BNP Levels Predict Hemodynamically Significant PDAs
NCT01497054
Patent Ductus Arteriosus
COMPLETED
Renal Doppler in Pediatric Patients With Idiopathic Nephrotic Syndrome
NCT05912673
Nephrotic Syndrome
COMPLETED
Impact of the Administration of Fludrocortisone in Very Premature Infants
NCT03001089
Partial Mineralocorticoid Deficiency
COMPLETED
PHASE2
Normal Pressure Hydrocephalus (NPH) Registry
NCT00233701
Normal Pressure Hydrocephalus
COMPLETED
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients with congenital hydronephrosis will be identified by inpatient consultations performed by Dr. Assadi for congenital hydronephrosis and by outpatient problem lists with congenital hydronephrosis of Dr. Assadi's existing patients. Once identified, the patient's grade of hydronephrosis will be recorded from initial ultrasound based on Society of Fetal Urology (SFU) classification. If no initial SFU classification was assigned to the hydronephrosis a pediatric radiologist will review the initial ultrasound images and classify the grade of hydronephrosis based upon SFU criteria. The patients ensuing evaluation of their hydronephrosis that took place will then be recorded and de-identified. Data to be collected will include: Ultrasound evaluations of the abdomen, retroperitoneum, or renal system, Voiding Cysto-Urethrogram (VCUGs), nuclear studies: diuretic enhanced technetium-99m dietylene triamine penta-acetic acid renogram (DTPA) or technetium-99m Mercapto-acetyl-triglycine renogram (MAG3), referral to pediatric urology for pyeloplasty, serum electrolytes, Blood Urea Nitrogen (BUN) and creatinine, urinalysis, urinary tract infections, and placement on long-term antibiotic prophylaxis.
The follow up evaluation that took place for each patient will then be compared to our proposed algorithm for congenital hydronephrosis evaluation and treatment. This algorithm will be designed based on clinical experience of expert opinion and literature review of each step in the evaluation and treatment. Primary outcomes will be progressive renal function decline and progression to referral to a pediatric urologist for pyeloplasty. Secondary outcomes will be incidence of urinary tract infections and placement on long term antibiotic prophylaxis for urinary tract infection prophylaxis.
The follow up evaluation that took place for each patient will then be compared to our proposed algorithm for congenital hydronephrosis evaluation and treatment. This algorithm will be designed based on clinical experience of expert opinion and literature review of each step in the evaluation and treatment. Primary outcomes will be progressive renal function decline and progression to referral to a pediatric urologist for pyeloplasty. Secondary outcomes will be incidence of urinary tract infections and placement on long term antibiotic prophylaxis for urinary tract infection prophylaxis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Congenital Hydronephrosis
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Observational Model Type
COHORT
Study Time Perspective
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bilateral Hydronephrosis Grade I-II
Patients with Bilateral Hydronephrosis Grade I-II
No interventions assigned to this group
Bil. Hydronephrosis Grade III-IV, Other
Patient with Bilateral Hydronephrosis Grade III-IV and others with any hydronephrosis and distended bladder or MCKD
No interventions assigned to this group
Unilateral Hydronephrosis Grade I-II
Patients with Unilateral Hydronephrosis Grades I-II
No interventions assigned to this group
Unilateral Hydronephrosis Grade III-IV
Patients with Unilateral Hydronephrosis Grade III-IV
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
* prior history of UTI
* diagnosis of cystic renal dysplasia with poorly functioning kidney
* previous operation on the urinary tract system
* and other deformities of the external genital organs or anomalies in cardiopulmonary and central nervous system
* diagnosis of cystic renal dysplasia with poorly functioning kidney
* previous operation on the urinary tract system
* and other deformities of the external genital organs or anomalies in cardiopulmonary and central nervous system
Maximum Eligible Age
2 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rush University Medical Center
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
RUSH University Medical Center, Pediatrics, Department of Nephrology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Farahnak Assadi, MD
Role: PRINCIPAL_INVESTIGATOR
RUSH University, Pediatrics, Nephrology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rush University Medical Center
Chicago, Illinois, United States
Site Status
Countries
Review the countries where the study has at least one active or historical site.
United States
References
Explore related publications, articles, or registry entries linked to this study.
Warady BA, Chadha V. Chronic kidney disease in children: the global perspective. Pediatr Nephrol. 2007 Dec;22(12):1999-2009. doi: 10.1007/s00467-006-0410-1. Epub 2007 Feb 20.
Reference Type
BACKGROUND
Mong Hiep TT, Ismaili K, Collart F, Van Damme-Lombaerts R, Godefroid N, Ghuysen MS, Van Hoeck K, Raes A, Janssen F, Robert A. Clinical characteristics and outcomes of children with stage 3-5 chronic kidney disease. Pediatr Nephrol. 2010 May;25(5):935-40. doi: 10.1007/s00467-009-1424-2. Epub 2010 Feb 11.
Reference Type
BACKGROUND
Ardissino G, Dacco V, Testa S, Bonaudo R, Claris-Appiani A, Taioli E, Marra G, Edefonti A, Sereni F; ItalKid Project. Epidemiology of chronic renal failure in children: data from the ItalKid project. Pediatrics. 2003 Apr;111(4 Pt 1):e382-7. doi: 10.1542/peds.111.4.e382.
Reference Type
BACKGROUND
Smith JM, Stablein DM, Munoz R, Hebert D, McDonald RA. Contributions of the Transplant Registry: The 2006 Annual Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS). Pediatr Transplant. 2007 Jun;11(4):366-73. doi: 10.1111/j.1399-3046.2007.00704.x.
Reference Type
BACKGROUND
Brown T, Mandell J, Lebowitz RL. Neonatal hydronephrosis in the era of sonography. AJR Am J Roentgenol. 1987 May;148(5):959-63. doi: 10.2214/ajr.148.5.959.
Reference Type
BACKGROUND
Palmer LS, Maizels M, Cartwright PC, Fernbach SK, Conway JJ. Surgery versus observation for managing obstructive grade 3 to 4 unilateral hydronephrosis: a report from the Society for Fetal Urology. J Urol. 1998 Jan;159(1):222-8. doi: 10.1016/s0022-5347(01)64072-2.
Reference Type
BACKGROUND
Grignon A, Filion R, Filiatrault D, Robitaille P, Homsy Y, Boutin H, Leblond R. Urinary tract dilatation in utero: classification and clinical applications. Radiology. 1986 Sep;160(3):645-7. doi: 10.1148/radiology.160.3.3526402.
Reference Type
BACKGROUND
Anderson N, Clautice-Engle T, Allan R, Abbott G, Wells JE. Detection of obstructive uropathy in the fetus: predictive value of sonographic measurements of renal pelvic diameter at various gestational ages. AJR Am J Roentgenol. 1995 Mar;164(3):719-23. doi: 10.2214/ajr.164.3.7863901.
Reference Type
BACKGROUND
Maizels M, Reisman ME, Flom LS, Nelson J, Fernbach S, Firlit CF, Conway JJ. Grading nephroureteral dilatation detected in the first year of life: correlation with obstruction. J Urol. 1992 Aug;148(2 Pt 2):609-14; discussion 615-6. doi: 10.1016/s0022-5347(17)36668-5.
Reference Type
BACKGROUND
Fernbach SK, Maizels M, Conway JJ. Ultrasound grading of hydronephrosis: introduction to the system used by the Society for Fetal Urology. Pediatr Radiol. 1993;23(6):478-80. doi: 10.1007/BF02012459.
Reference Type
BACKGROUND
Conway JJ, Maizels M. The "well tempered" diuretic renogram: a standard method to examine the asymptomatic neonate with hydronephrosis or hydroureteronephrosis. A report from combined meetings of The Society for Fetal Urology and members of The Pediatric Nuclear Medicine Council--The Society of Nuclear Medicine. J Nucl Med. 1992 Nov;33(11):2047-51.
Reference Type
BACKGROUND
Herndon CD, McKenna PH, Kolon TF, Gonzales ET, Baker LA, Docimo SG. A multicenter outcomes analysis of patients with neonatal reflux presenting with prenatal hydronephrosis. J Urol. 1999 Sep;162(3 Pt 2):1203-8. doi: 10.1016/S0022-5347(01)68134-5.
Reference Type
BACKGROUND
Ismaili K, Avni FE, Piepsz A, Wissing KM, Cochat P, Aubert D, Hall M. Current management of infants with fetal renal pelvis dilation: a survey by French-speaking pediatric nephrologists and urologists. Pediatr Nephrol. 2004 Sep;19(9):966-71. doi: 10.1007/s00467-004-1506-0. Epub 2004 Jul 6.
Reference Type
BACKGROUND
Lee JH, Choi HS, Kim JK, Won HS, Kim KS, Moon DH, Cho KS, Park YS. Nonrefluxing neonatal hydronephrosis and the risk of urinary tract infection. J Urol. 2008 Apr;179(4):1524-8. doi: 10.1016/j.juro.2007.11.090. Epub 2008 Mar 4.
Reference Type
BACKGROUND
Keays MA, Guerra LA, Mihill J, Raju G, Al-Asheeri N, Geier P, Gaboury I, Matzinger M, Pike J, Leonard MP. Reliability assessment of Society for Fetal Urology ultrasound grading system for hydronephrosis. J Urol. 2008 Oct;180(4 Suppl):1680-2; discussion1682-3. doi: 10.1016/j.juro.2008.03.107. Epub 2008 Aug 16.
Reference Type
BACKGROUND
Yerkes EB, Adams MC, Pope JC 4th, Brock JW 3rd. Does every patient with prenatal hydronephrosis need voiding cystourethrography? J Urol. 1999 Sep;162(3 Pt 2):1218-20. doi: 10.1016/S0022-5347(01)68138-2.
Reference Type
BACKGROUND
Wiener JS, O'Hara SM. Optimal timing of initial postnatal ultrasonography in newborns with prenatal hydronephrosis. J Urol. 2002 Oct;168(4 Pt 2):1826-9; discussion 1829. doi: 10.1097/01.ju.0000030859.88692.dd.
Reference Type
BACKGROUND
Docimo SG. Re: Optimal timing of initial postnatal ultrasonography in newborns with prenatal hydronephrosis. J Urol. 2003 Apr;169(4):1474; author reply 1474. doi: 10.1097/01.ju.0000053374.59414.58. No abstract available.
Reference Type
BACKGROUND
Yang Y, Hou Y, Niu ZB, Wang CL. Long-term follow-up and management of prenatally detected, isolated hydronephrosis. J Pediatr Surg. 2010 Aug;45(8):1701-6. doi: 10.1016/j.jpedsurg.2010.03.030.
Reference Type
BACKGROUND
Sidhu G, Beyene J, Rosenblum ND. Outcome of isolated antenatal hydronephrosis: a systematic review and meta-analysis. Pediatr Nephrol. 2006 Feb;21(2):218-24. doi: 10.1007/s00467-005-2100-9. Epub 2005 Dec 17.
Reference Type
BACKGROUND
Estrada CR, Peters CA, Retik AB, Nguyen HT. Vesicoureteral reflux and urinary tract infection in children with a history of prenatal hydronephrosis--should voiding cystourethrography be performed in cases of postnatally persistent grade II hydronephrosis? J Urol. 2009 Feb;181(2):801-6; discussion 806-7. doi: 10.1016/j.juro.2008.10.057. Epub 2008 Dec 17.
Reference Type
BACKGROUND
Moorthy I, Joshi N, Cook JV, Warren M. Antenatal hydronephrosis: negative predictive value of normal postnatal ultrasound--a 5-year study. Clin Radiol. 2003 Dec;58(12):964-70. doi: 10.1016/s0009-9260(03)00171-5.
Reference Type
BACKGROUND
Maizels M, Alpert SA, Houston JT, Sabbagha RE, Parilla BV, MacGregor SN. Fetal bladder sagittal length: a simple monitor to assess normal and enlarged fetal bladder size, and forecast clinical outcome. J Urol. 2004 Nov;172(5 Pt 1):1995-9. doi: 10.1097/01.ju.0000142136.17222.07.
Reference Type
BACKGROUND
Homsy YL, Saad F, Laberge I, Williot P, Pison C. Transitional hydronephrosis of the newborn and infant. J Urol. 1990 Aug;144(2 Pt 2):579-83; discussion 593-4. doi: 10.1016/s0022-5347(17)39527-7.
Reference Type
BACKGROUND
Peters CA, Skoog SJ, Arant BS Jr, Copp HL, Elder JS, Hudson RG, Khoury AE, Lorenzo AJ, Pohl HG, Shapiro E, Snodgrass WT, Diaz M. Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in Children. J Urol. 2010 Sep;184(3):1134-44. doi: 10.1016/j.juro.2010.05.065. Epub 2010 Jul 21.
Reference Type
BACKGROUND
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10020402
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Salt Wasting, Hydro-sodium Balance and Fludrocortisone Requirement in Congenital Adrenal Hyperplasia
NCT03550261
COMPLETED
Uncovering the Etiologies of Non-immune Hydrops Fetalis
NCT05528796
ENROLLING_BY_INVITATION
NA
Volumetrics and Proteomics in Shunted Normal Pressure Hydrocephalus
NCT04785560
ACTIVE_NOT_RECRUITING
NA
Arginin-stimulated Copeptin in Polyuria-polydipsia Syndrome in Children
NCT06604975
NOT_YET_RECRUITING
NA
Relationship of Brain Natriuretic Peptide (BNP) Levels to Cardiac Diagnosis, Operation Performed, Post-operative Course and Outcome
NCT00238810
COMPLETED
End-organ Pathology in Childhood Essential Hypertension
NCT00005180
COMPLETED
Establishment of a Database for Long-Term Monitoring of Patients With Nephropathic Cystinosis
NCT00004312
COMPLETED
Newborn Screening for Congenital Heart Disease
NCT01665261
COMPLETED
Electronic Archive of Patients With Diagnosis and Suspected Prenatal Diagnosis of Aortic Coarctation
NCT06759103
RECRUITING
Implementation of a Diagnostic Workflow for Personalized Diagnosis of Nephrotic Syndrome
NCT06325098
RECRUITING
NA
Recognition of Abnormal Pediatric Blood Pressures in Primary Care
NCT00130663
COMPLETED
NA
Assessment of ShuntCheck Performance Characteristics in Asymptomatic Patients With Normal Pressure Hydrocephalus
NCT04011566
UNKNOWN
DeHydration: Assessing Kids Accurately
NCT02007733
COMPLETED
Incidence of Hypertrophic Cardiomyopathy in Infants of Diabetic Mothers Attending in NICU at Assiut University Children Hospital During One Year
NCT06048562
COMPLETED
NA
Ductus Arteriosus Closure and D-Dimer and Fibrinogen Levels
NCT04508036
UNKNOWN
B-type Natriuretic Peptide in the Non-Cardiac Pediatric Patient
NCT00330811
COMPLETED
Retrospective Multicentre Study on the Impact of Neonatal Screening for Congenital Adrenal Hyperplasia in Italy
NCT06728748
RECRUITING
Whole Exome Sequencing and Whole Genome Sequencing for Nonimmune Fetal/Neonatal Hydrops
NCT03911531
RECRUITING
Role of Brain Specific Biomarkers in Hydrocephalus
NCT06083233
COMPLETED
Renal Anhydramnios Fetal Therapy
NCT03101891
ACTIVE_NOT_RECRUITING
PHASE1
Fontan Associated Liver Disease
NCT03914196
ACTIVE_NOT_RECRUITING
Prevelance of Hypercalciuria in Children With Steroid Dependent Nephrotic Syndrome
NCT07194213
ACTIVE_NOT_RECRUITING
Study of Adrenocorticotropic Hormone on Children With Frequent Relapse or Steroid-dependent Nephrotic Syndrome: a Prospective, Multicenter, Randomized，Open-label Clinical Trial.
NCT06079788
RECRUITING
PHASE3
Early Detection of Progressive Kidney Disease in Preterm Infants
NCT02000895
RECRUITING
Hydrops: Diagnosing & Redefining Outcomes With Precision Study
NCT03412760
ACTIVE_NOT_RECRUITING
NA